share_log

康諾亞-B:自願性公告 CM310 III期臨床試驗頂線數據入選2023年歐洲皮膚病與性病學會(EADV)年會壁報

KEYMED BIO-B: VOLUNTARY ANNOUNCEMENT CM310 PHASE III CLINICAL TRIAL TOPLINE DATA ACCEPTED FOR POSTER SESSION AT THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) CONGRESS 2023

香港交易所 ·  Oct 11, 2023 04:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more